Kevin Schuyler

CIK: 0001718094

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ADIL

ADIAL PHARMACEUTICALS, INC.

Director

VEEE

Twin Vee PowerCats, Co.

Director

FRZA

Forza X1, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ADIL
ADIAL PHARMACEUTICALS, INC.
Apr 7, 2026
Award(A)
Direct
9.2K shares-
VEEE
Twin Vee PowerCats, Co.
Mar 19, 2026
Purchase(P)
Direct
25K shares at avg. $0.41$10K
ADIL
ADIAL PHARMACEUTICALS, INC.
May 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
VEEE
Twin Vee PowerCats, Co.
May 19, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3K shares-
FRZA
Forza X1, Inc.
Nov 26, 2024
Disposition(D)
Direct
100K shares-
VEEE
Twin Vee PowerCats, Co.
Nov 26, 2024
Award(A)
Direct
61.2K shares-
FRZA
Forza X1, Inc.
Sep 17, 2024
Purchase(P)
Direct
90.7K shares at avg. $0.30$27K

		Type	Shares	Price		Ownership
Apr 7, 2026	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A)	9,185	-	$0	Direct
Mar 19, 2026	VEEE Twin Vee PowerCats, Co.	Purchase(P)	25,000	$0.41	$10,165	Direct
May 29, 2025	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
May 19, 2025	VEEE Twin Vee PowerCats, Co.	Award(A) Stock Option (Right to Buy)	3,000	-	-	Direct
Nov 26, 2024	FRZA Forza X1, Inc.	Disposition(D)	100,000	-	$0	Direct
Nov 26, 2024	VEEE Twin Vee PowerCats, Co.	Award(A)	61,166	-	$0	Direct
Sep 17, 2024	FRZA Forza X1, Inc.	Purchase(P)	90,668	$0.30	$27,200	Direct

1-7 of 7 transactions

About Schuyler Kevin

Schuyler Kevin (SEC CIK 0001718094) files insider reports with the SEC as Director of ADIAL PHARMACEUTICALS, INC. (ADIL), Director of Twin Vee PowerCats, Co. (VEEE) and Director of Forza X1, Inc. (FRZA).

Signal8 holds 7 ownership filings by Schuyler Kevin, all Form 4s, filed between Sep 18, 2024 and Apr 9, 2026. Those filings report 7 transactions, from Sep 17, 2024 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schuyler Kevin's filings is in GLEN ALLEN, VA.

Recent filings by Schuyler Kevin

Apr 7, 2026: Grant or award of ADIL shares (Form 4, code A).
Mar 19, 2026: Open-market purchase of VEEE shares (Form 4, code P).
May 29, 2025: Grant or award of ADIL derivative securities (Form 4, code A).
May 19, 2025: Grant or award of VEEE derivative securities (Form 4, code A).
Nov 26, 2024: Disposition to issuer transaction of FRZA shares (Form 4, code D).

Other insiders filing for ADIAL PHARMACEUTICALS, INC. (ADIL)

Davidson Matt, President and CEO
Saiki Julie, Chief Strategy Officer
Economides Vassiliki, Chief Financial Officer
Young Wendy B., Director
Coastlands Capital LP, 10% Owner
Goodman Tony, Chief Operating Officer

How to read Form 4 transaction codes